Medicare Enrolled
Dr. William Kaye, M.D.
Endocrinology · West Palm Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kaye from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaye? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaye
Dr. William Kaye is an endocrinology in West Palm Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kaye performed 24,170 Medicare services across 11,541 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kaye received a total of $467,011 from 74 pharmaceutical and/or device companies across 1135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaye is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in FL$ $467,011 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,170
Medicare services
Top 3% in FL for endocrinology
11,541
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,272 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 2,279 | $8 | $10 |
| Office visit, established patient (30-39 min) | 2,177 | $94 | $205 |
| Comprehensive metabolic blood panel | 1,830 | $10 | $60 |
| Lipid panel (cholesterol and triglycerides) | 1,394 | $13 | $38 |
| Automated urinalysis | 1,298 | $2 | $10 |
| Creatinine test (kidney function) | 1,201 | $5 | $15 |
| Urine microalbumin (protein) analysis | 1,198 | $6 | $17 |
| Glycated protein level | 1,172 | $16 | $43 |
| Thyroid stimulating hormone (TSH) test | 1,158 | $16 | $48 |
| Carbohydrate analysis, single quantitative | 1,143 | $11 | $40 |
| Chronic care management, first 20 min/month | 1,143 | $48 | $100 |
| Free thyroxine (T4) test | 1,127 | $9 | $30 |
| Blood glucose (sugar) measurement using reagent strip | 1,038 | $5 | $6 |
| Complete blood count (CBC) with differential | 964 | $8 | $50 |
| Remote patient monitoring management, 20 min/month | 822 | $38 | $120 |
| Remote patient monitoring device, 30 days | 569 | $38 | $110 |
| Vitamin B-12 level test | 408 | $15 | $40 |
| Vitamin D level test | 288 | $29 | $80 |
| Ultrasound scan of head and neck soft tissue | 285 | $86 | $224 |
| Parathyroid hormone level test | 277 | $40 | $118 |
| Thyroid hormone, t3 measurement, total | 228 | $14 | $41 |
| Hemoglobin A1c test (diabetes monitoring) | 209 | $9 | $28 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 199 | $27 | $86 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 161 | $43 | $100 |
| New patient office visit (45-59 min) | 135 | $122 | $318 |
| Office visit, established patient (20-29 min) | 123 | $65 | $136 |
| Chronic care management, additional 20 min/month | 109 | $38 | $80 |
| Testosterone (hormone) level, total | 105 | $25 | $74 |
| Gonadotropin, luteinizing (reproductive hormone) level | 91 | $18 | $53 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 90 | $18 | $53 |
| Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 90 | $12 | $60 |
| Psa (prostate specific antigen) measurement, free | 79 | $18 | $60 |
| PSA test (prostate cancer screening) | 70 | $18 | $53 |
| Microsomal antibodies (autoantibody) measurement | 66 | $14 | $50 |
| Cortisol (hormone) measurement, total | 62 | $16 | $47 |
| Adrenocorticotropic hormone (acth) level | 60 | $38 | $111 |
| Kidney function blood test panel | 55 | $9 | $100 |
| Thyroid hormone, t3 measurement, free | 55 | $17 | $45 |
| Magnesium level test | 49 | $7 | $19 |
| C-peptide (protein) level | 41 | $20 | $55 |
| Thyroglobulin (thyroid protein) antibody measurement | 39 | $16 | $60 |
| Prolactin (milk producing hormone) level | 27 | $19 | $56 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 21 | $13 | $37 |
| Human growth hormone level | 20 | $16 | $48 |
| Thyroxine (thyroid chemical), total | 20 | $7 | $25 |
| Somatomedin (growth factor) level | 19 | $21 | $56 |
| Thyroid hormone evaluation | 19 | $6 | $20 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 18 | $14 | $60 |
| Calcium level, total | 17 | $5 | $15 |
| Calcitonin (hormone) level | 16 | $26 | $77 |
| Thyroglobulin (thyroid related hormone) level | 16 | $16 | $46 |
| Flu vaccine, high-dose | 16 | $72 | $100 |
| Flu vaccine administration | 16 | $29 | $30 |
| Thyroid stimulating immune globulins (thyroid related protein) level | 15 | $50 | $120 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 15 | $33 | $80 |
| Phosphate level test | 14 | $5 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 14 | $110 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$467,011
Total received (2018-2024)
Avg $66,716/year across 7 years
Top 2% in FL for endocrinology
74
Companies
1,135
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$450,207 (96.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,651 (2.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,153 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$115,899
2023$91,600
2022$70,539
2021$45,353
2020$33,293
2019$59,499
2018$50,829
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$187,639
Novo Nordisk Inc
$126,805
Boehringer Ingelheim Pharmaceuticals, Inc.
$76,090
AstraZeneca Pharmaceuticals LP
$24,945
Merck Sharp & Dohme Corporation
$18,188
SANOFI-AVENTIS U.S. LLC
$9,757
Bayer Healthcare Pharmaceuticals Inc.
$6,028
AbbVie, Inc.
$5,060
AbbVie Inc.
$1,678
Eli Lilly and Company
$1,393
Abbott Laboratories
$1,185
Tosoh Bioscience, Inc.
$1,105
Amgen Inc.
$785
Mannkind Corporation
$636
Insulet Corporation
$542
Novartis Pharmaceuticals Corporation
$408
Xeris Pharmaceuticals, Inc.
$357
Tandem Diabetes Care, Inc.
$352
MannKind Corporation
$323
ABBVIE INC.
$276
Bayer HealthCare Pharmaceuticals Inc.
$276
Radius Health, Inc.
$268
Antares Pharma, Inc.
$254
Ipsen Biopharmaceuticals, Inc
$209
Amarin Pharma Inc.
$198
Medtronic, Inc.
$193
Amneal Pharmaceuticals LLC
$172
Horizon Therapeutics plc
$162
Dexcom, Inc.
$147
BETA BIONICS, INC.
$146
LifeScan, Inc.
$98
Medtronic MiniMed, Inc.
$72
VIVUS LLC
$71
VIVUS, Inc.
$70
Senseonics, Incorporated
$69
Shire North American Group Inc
$63
Aytu BioScience, Inc
$58
PFIZER INC.
$55
Alvogen Inc
$54
Corcept Therapeutics
$52
Supernus Pharmaceuticals, Inc.
$49
Ultragenyx Pharmaceutical Inc.
$48
Nevro Corp.
$44
Verity Pharmaceuticals Inc.
$37
SANOFI PASTEUR INC.
$36
Orexigen Therapeutics, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$34
Quidel Corporation
$32
Companion Medical, Inc.
$30
Neurocrine Biosciences, Inc.
$28
Acerus Pharmaceuticals Corporation
$27
Averitas Pharma Inc.
$24
Ascendis Pharma Inc
$23
Alexion Pharmaceuticals, Inc.
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Regeneron Healthcare Solutions, Inc.
$20
Endo Pharmaceuticals Inc.
$19
Vanda Pharmaceuticals Inc.
$18
Sanofi Pasteur Inc.
$18
Kyowa Kirin, Inc.
$17
Alnylam Pharmaceuticals Inc.
$17
Ferring Pharmaceuticals Inc.
$16
Tolmar, Inc.
$15
VistaPharm, Inc.
$15
Esperion Therapeutics, Inc.
$14
Amryt Pharma Holdings Ltd
$14
RECORDATI_RARE_DISEASES_INC.
$14
LIFESCAN, INC.
$13
Strongbridge US INC.
$13
Seqirus USA Inc
$12
Cardiovascular Systems Inc.
$12
Eisai Inc.
$12
Acella Pharmaceuticals, LLC
$11
Nalpropion Pharmaceuticals LLC
$11
Top 3 companies account for 83.6% of total payments
Associated products mentioned in payments ›
25-OH Vitamin D ST AIA-Pack · AFREZZA · AIA-PACK Calibrator Set · Androgel · BAQSIMI · C-PEPTIDE · CONTRAVE · CYCLOSET · Corlanor · Crysvita · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Eversense · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GIVLAARI · GVOKE HYPOPEN · GVOKE PFS · HAWKONE · HETLIOZ · HUMULIN · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LYRICA · Lenvima · MACRILEN · MINIMED 780G · MOUNJARO · Macrilen · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid · Natesto · Non-Covered · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Prolia · QSYMIA · QUTENZA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNJARDY · SYNTHROID · Saxenda · Senza · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TU · TZIELD · Thyquidity · Tlando · Tresiba · Triage · Tymlos · UNITHROID · Vascepa · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in FL.
Equivalent to $1,932 per 100 Medicare services performed
Geographic Context
Endocrinologys within 10 mi
39
Per 100K population
2.6
County median income
$81,115
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kaye is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kaye experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Kaye performed 2,279 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kaye receive payments from pharmaceutical companies?
Yes. Dr. Kaye received a total of $467,011 from 74 companies across 1,135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaye's costs compare to other endocrinologys in West Palm Beach?
Dr. Kaye's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaye) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in West Palm Beach
Browse endocrinologys in West Palm Beach ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in FL
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in FL
Which FL endocrinologys receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology